Solid Carcinoma — Trials

Solid Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

32 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 17
Recruiting: 12
Ph III recruiting: 1
Growth YoY: —
Industry share: 29%
Top sponsor: Memorial Sloan Kettering Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02974738	A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)	active not recruiting	Phase 1	120	Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)INDUSTRY	0	Sep 16, 2026	clinicaltrials
NCT06475937	A Study of DM001 in Patients With Advanced Solid Tumors	active not recruiting	Phase 1	128	Xadcera Biopharmaceutical (Suzhou) Co., Ltd.INDUSTRY	2